Cavallieri, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 6.142
AS - Asia 4.554
EU - Europa 2.622
SA - Sud America 686
AF - Africa 112
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.149
Nazione #
US - Stati Uniti d'America 5.958
SG - Singapore 1.571
CN - Cina 1.280
IT - Italia 696
VN - Vietnam 526
BR - Brasile 502
GB - Regno Unito 471
HK - Hong Kong 460
SE - Svezia 315
DE - Germania 223
KR - Corea 184
FI - Finlandia 182
RU - Federazione Russa 174
FR - Francia 130
CA - Canada 94
IN - India 92
TR - Turchia 81
AR - Argentina 63
ID - Indonesia 62
MX - Messico 62
NL - Olanda 60
BD - Bangladesh 58
UA - Ucraina 52
ES - Italia 51
BG - Bulgaria 43
IE - Irlanda 41
JP - Giappone 38
PL - Polonia 36
ZA - Sudafrica 34
AT - Austria 31
EC - Ecuador 30
IQ - Iraq 28
PK - Pakistan 27
AU - Australia 26
CO - Colombia 22
VE - Venezuela 19
CZ - Repubblica Ceca 18
LT - Lituania 18
MA - Marocco 18
CL - Cile 17
AE - Emirati Arabi Uniti 15
IL - Israele 15
PH - Filippine 15
UZ - Uzbekistan 15
EG - Egitto 14
NP - Nepal 13
CH - Svizzera 11
MY - Malesia 11
PE - Perù 11
PT - Portogallo 11
KE - Kenya 10
TN - Tunisia 10
BE - Belgio 9
DZ - Algeria 9
PY - Paraguay 9
TW - Taiwan 9
UY - Uruguay 9
SA - Arabia Saudita 8
NO - Norvegia 7
RS - Serbia 7
CR - Costa Rica 6
JO - Giordania 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
BH - Bahrain 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
GT - Guatemala 4
HU - Ungheria 4
BB - Barbados 3
EE - Estonia 3
IR - Iran 3
LB - Libano 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
GE - Georgia 2
GH - Ghana 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
FJ - Figi 1
Totale 14.130
Città #
Singapore 1.026
Santa Clara 860
Ashburn 737
Hefei 533
Hong Kong 454
Fairfield 438
San Jose 355
Chandler 323
Woodbridge 221
Seoul 177
London 175
Seattle 169
Ho Chi Minh City 168
Houston 167
Beijing 166
Cambridge 154
Nyköping 150
Wilmington 148
Southend 147
Helsinki 143
Los Angeles 133
Hanoi 127
The Dalles 126
Chicago 116
Modena 116
Council Bluffs 102
New York 97
Dearborn 83
Ann Arbor 71
Jacksonville 70
Munich 64
Lauterbourg 57
Moscow 52
San Diego 52
Dallas 45
Salt Lake City 43
Jakarta 42
São Paulo 42
Bologna 41
Princeton 40
Sofia 40
Rome 39
Shanghai 38
Buffalo 36
Milan 35
Orem 33
Dublin 32
Tokyo 31
Bremen 29
Chennai 28
Denver 28
Frankfurt am Main 28
Rio de Janeiro 27
Warsaw 27
Da Nang 26
Istanbul 26
Montreal 26
Kent 25
Haiphong 22
Elk Grove Village 21
Eugene 20
Johannesburg 20
Lappeenranta 20
Mexico City 20
Amsterdam 19
Brooklyn 19
Parma 19
Stockholm 19
Manchester 18
Redwood City 18
Vienna 18
Nuremberg 17
Redondo Beach 17
Atlanta 16
Hải Dương 16
Izmir 16
Madrid 16
Poplar 15
Reggio Emilia 15
Toronto 15
Des Moines 14
Phoenix 14
Turku 14
Biên Hòa 13
Morgantown 13
Tashkent 13
Brasília 12
Tampa 12
Baghdad 11
Boston 11
Dhaka 11
Florence 11
Norwalk 11
Sydney 11
Yalova 11
Carpi 10
City of London 10
Guayaquil 10
Hillsboro 10
Olomouc 10
Totale 9.412
Nome #
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 369
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 341
Acute hemichorea as unusual first multiple sclerosis presentation 326
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 315
Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis 291
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 289
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment 276
Usefulness of Thromboelastography in the Detection and Management of Tissue Plasminogen Activator-Associated Hyperfibrinolysis 268
Condition monitoring of parkinson pathological tremor for functional electrical stimulation control 263
C9ORF72 and parkinsonism: Weak link, innocent bystander, or central player in neurodegeneration? 257
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? 257
Cortical action myoclonus due to cortical laminar necrosis 245
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 245
The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease 244
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 244
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 242
Insights into healthcare professionals’ perceptions and attitudes toward nanotechnological device application: What is the current situation in glioblastoma research? 240
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson’s disease: a clinical-instrumental study 236
Freezing of gait in Parkinson’s disease patients treated with bilateral subthalamic nucleus deep brain stimulation: A long-term overview 235
Exploring implication of dysfunctional cellular pathways in Parkinson's disease: Lysosomal-PD and mitochondrial-PD 234
Cervical dystonia in a case of longstanding secondary progressive multiple sclerosis 233
"Somewhere Between an Actual Disease and a Disease": A Grounded Theory Study on Diagnosing Functional Neurological Disorders From a Multi-Informant Perspective 227
Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12 221
Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 218
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease 208
Something that Touches your Heart: an Unusual Case of Abdominal Clonic Movements 208
Facial palsy during the COVID-19 pandemic 205
Quantitative dopamine transporter imaging assessment in Parkinson’s disease (PD) patients carrying GBA gene mutations compared with Idiopathic PD patients: A case-control study 200
Cerebral amyloid-β deposition, axial features, and cognitive alterations in patients with Parkinson’s disease treated with bilateral STN-DBS: A long-term cohort study 200
Levodopa responsive asymmetric parkinsonism as clinical presentation of progranulin gene mutation 199
Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease 195
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 195
MRI correlates of Parkinson's disease progression: A voxel based morphometry study 188
Vestibular­ and­ saccadic­ abnormalities­ in ­Parkinson's­ disease­ patients: ­Possible ­marker ­of­neurodegenerative­ burdern? 183
STUDIO SULL'ASSOCIAZIONE TRA SINTOMI ASSIALI, ALTERAZIONI COGNITIVE, VARIABILI CLINICO-STRUMENTALI DELLA FUNZIONE MOTORIA E DEPOSIZIONE DI BETA-AMILOIDE CEREBRALE IN PAZIENTI AFFETTI DA MALATTIA DI PARKINSON SOTTOPOSTI AD INTERVENTO DI STIMOLAZIONE CEREBRALE PROFONDA DEL NUCLEO SUBTALAMICO 181
Idiopathic brain calcification in a patient with hereditary hemochromatosis 179
Extracranial metastases in secondary glioblastoma multiforme: a case report 177
Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview 177
Case Report: Pituitary metastasis as a presenting manifestation of silent gastric cardia adenocarcinoma 175
A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease 175
A novel neurophysiological finding in essential palatal tremor 171
Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association 170
A Case of Peripherally Induced Task-Specific "Lipstick Dystonic Tremor" 163
Epileptogenesis and Tumorigenesis in Glioblastoma: Which Relationship? 159
Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene 151
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection 149
Longitudinal Neuropsychological Assessment of Symptomatic Edema after Subthalamic Nucleus Deep Brain Stimulation Surgery: A Case Series Study 147
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence? 144
To be or not to be: The dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma – a systematic review and meta-analysis 143
A Case of 18p Chromosomal Deletion Encompassing GNAL in a Patient With Dystonia-Parkinsonism 143
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope? 142
Analysis of a peculiar motor speech disorder in a case of probable progressive supranuclear palsy 141
Recurrent Falls as the Only Clinical Sign of Cortical–Subcortical Myoclonus: A Case Report 138
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology) 138
Are you tuned in to others' mind? A cross-modal evaluation of affective theory of mind in people with Parkinson's disease 136
Glioblastoma and malignant melanoma: Serendipitous or anticipated association? 136
EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic 134
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype? 133
C9ORF72 hexanucleotide expansion and parkinsonism: weak link, innocent bystander, or central player in neurodegeneration? 130
Steroid-Responsive Acute Left-Arm Chorea as a Presenting Symptom of Moyamoya Disease 128
Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease 127
Speech, Gait, and Vestibular Function in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome 127
Just smile or not? A case of isolated smiling tremor 124
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study 123
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry 116
Vestibular Hypofunction in ARSACS Syndrome: A Possible Pitfall in the Differential Diagnosis of Recessive Cerebellar and Afferent Ataxias. 116
Artificial intelligence predicts GBA1 mutated status in Parkinson’s Disease patients 107
Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review 107
Clinical implications of double heterozygosity for SPG4 and SPG7 mutations: a case report 99
Dopa responsive dystonia due to a GCH1 gene variant mimicking hereditary spastic paraparesis 90
Subcortical generalized myoclonus as a presenting symptom of quetiapine overdose 88
VOLTAGE-GATED POTASSIUM CHANNEL (VGKC)AUTOANTIBODIES-ASSOCIATED ENCEPHALITIS AND KREUTZFELDT-JAKOB DISEASE: A CASE OF COMPLETE CLINICAL, IMAGING, AND LABORATORY OVERLAP 84
A De Novo SCN2A Variant in a Patient with Adult‐Onset Dystonia Parkinsonism and Nigrostriatal Denervation 81
Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting 80
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease 79
First motor seizure as presenting symptom of SARS-CoV-2 infection 79
Retinal structural changes in Parkinson’s disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases 76
TIA: multiple vascular risk factors and vascular anomalies, who is guilty? 73
Speech profile in different clinical PSP phenotypes: an acoustic-perceptual study 68
18F-FDG PET findings in Parkinson's disease associated to RAB32 S71R variant 65
Surface Dynamic Gait EMG Assessment of Paroxysmal Muscle Spasm in Stiff‐Person Syndrome 59
Citalopram-Induced Tongue Dyskinesia 59
Totale 14.284
Categoria #
all - tutte 56.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 48 56
2021/2022750 46 69 17 33 30 50 28 31 91 98 180 77
2022/2023911 76 113 62 93 96 141 17 78 110 9 43 73
2023/2024816 37 59 69 113 98 62 60 79 27 24 92 96
2024/20253.339 69 29 154 227 615 558 286 170 321 141 344 425
2025/20266.524 570 299 633 916 1.001 408 861 304 828 624 80 0
Totale 14.284